Low dose and long term toxicity of sodium arsenite caused caspase dependent apoptosis based on morphology and biochemical character

Cell Journal

Volumn 14, Issue 3, 2012, Pages 161-170

  Abnosi, Mohammad Hussein ^a   Yazdi, Zahra Jafari ^a  

^a ARAK UNIVERSITY   (Iran)

Author keywords

Apoptosis; Cell viability; Mesenchymal stem cell; Rat; Sodium arsenite

Indexed keywords

ARSENITE SODIUM; CASPASE 3; CELL DNA;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CELL VIABILITY; CELLULAR PARAMETERS; COLONY FORMATION; COMET ASSAY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DNA STRAND BREAKAGE; EXPERIMENTAL STUDY; MALE; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; NUCLEAR SIZE; POPULATION DOUBLING NUMBER; RAT;

EID: 84872105420     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Singh KP, DuMond JW Jr. Genetic and epigenetic changes induced by chronic low dose exposure to arsenic of mouse testicular Leydig cells. Int J Oncol. 2007; 30(1): 253-260.
2. Chan PC, Huff J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcino Ecotox Revs. 1997; 15(2): 83-122.
3. Lewis AS. Organic versus inorganic arsenic in herbal kelp supplements. Environ Health Perspect. 2007; 115(12): A575-577.
4. Sidhu JS, Ponce RA, Vredevoogd MA, Yu X, Gribble E, Hong SW, et al. Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells. Toxicol Sci. 2006; 89(2): 475-484.
5. Tenorio EP, Saavedra R. Differential effect of sodium arsenite during the activation of human CD4 + and CD8 + T lymphocytes. Int Immunopharmacol. 2005; 5(13-14): 1853-1869.
6. 6- Watson RW, Redmond HP, Wang JH, Bouchier-Hayes D. Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils. J Leukoc Biol. 1996; 60(5): 625-632.
7. Kann S, Estes C, Reichard JF, Huang MY, Sartor MA, Schwemberger S, et al. Butylhydroquinone protects cells genetically deficient in glutathione biosynthesis from arsenite-induced apoptosis without significantly changing their prooxidant status. Toxicol Sci. 2005; 87 (2): 365-384.
8. Yadav S, Shi Y, Wang F, Wang H. Arsenite induces apoptosis in human mesenchymal stem cells by altering Bcl-2 family proteins and by activating intrinsic pathway. Toxicol Appl Pharmacol. 2010; 244(3): 263-272.
9. Jin Y, Sun G, Li X, Li G, Lu C, Qu L. Study on the toxic effects induced by different arsenicals in primary cultured rat astroglia. Toxicol Appl Pharmacol. 2004; 196(3): 396- 403.
10. Liao WT, Lin P, Cheng TS, Yu HS, Chang LW. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells. Toxicol Appl Pharmacol. 2007; 225(2): 162-170.
11. Lee PC, Ho IC, Lee TC. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant Protein-1, and Interleukin-6 in Vascular Smooth Muscle Cells. Toxicol Sci. 2005; 85(1): 541-550.
12. Florea AM, Splettstoesser F, Büsselberg D. Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl Pharmacol. 2007; 220(3): 292-301.
13. Clewell HJ, Thomas RS, Gentry PR, Crump KS, Kenyon EM, El-Masri HA, et al. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: A progress report. Toxicol Appl Pharmacol. 2007; 222(3): 388-398.
14. Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist. 2001; 6(2): 1-2.
15. Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene. 2001; 20(49): 7146-7153.
16. McCollum G, Keng G, States JC, McCabe MJ Jr. Arsenite delays progression through each cell cycle phase and induces apoptosis following G2/M arrest in U937 myeloid leukemia cells. J Pharmacol Exp Ther. 2005; 313(2): 877-887.
17. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia(APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997; 89: 3354-3360.
18. Wollert KC, Drexler H. Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation. 2005; 112(2): 151-153.
19. Baghban EslamiNejad MR, Nikmahzar A, Taghiyar L, Dehghan MM, Kazemi H, et al. Osteogenic, chondrogenic and adipogenic potentials of canine marrow-derived mesenchymal stem cells. Cell J. 2007; 9(1): 31-38.
20. Abnosi MH, Soleimani Mehranjani M, Momeni HR, Mahdieh Najafabadi M, Shojafar E, Barati M. Effect of sodium arsenite on rat bone marrow mesenchymal stem cells: cells viability and morphological study. Scientific journal of Hamadan University of Medical Sciences. 2010; 17(2): 10.
21. Kitareewan S, Roebuck BD, Demidenko E, Sloboda RD, Dmitrovsky E. Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J Natl Cancer Inst. 2007; 99 (1): 41-52.
22. Che XF, Zheng CL, Owatari S, Mutoh M, Gotanda T, Jeung HC, et al. Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines. Blood. 2006; 107(12): 4880-4887.
23. Lynn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-indused oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000; 86(5): 514-519.
24. Yancy SL, Shelden EA, Gilmont RR, Welsh MJ. Sodium arsenite exposure alters cell migration, focal adhesion localization and decreases tyrosine phosphorylation of focal adhesion kinase in H9C2 myoblasts. Toxicol Sci. 2005; 84(2): 278-286.
25. Sciandrello G, Barbaro R, Caradonna F, Barbata G. Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. Mutagenesis. 2002; 17(2): 99-103.
26. Zhou J, Ye J, Zhao X, Li A, Zhou J. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol Appl Pharmacol. 2008; 230(1): 33-40.
27. Miller WH Jr., Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 2002; 62(14): 3893-3903.
28. Othman F, Motalleb G, Tsuey Peng SL, Rahmat A, Fakurazi S, Pei Pei C. Extract of azadirachta indica (Neem) leaf Induces apoptosis in 4T1 breast cancer BALB/c Mice. Cell J. 2011; 13(2): 107-116.